Liberum
MENU

News

Liberum appointed Joint Corporate Broker to MedicX Fund Limited

10 May 2018 | Joint Corporate Broker

Medicxfund

Liberum is pleased to announce its appointment as Joint Corporate Broker to MedicX Fund Limited.

MedicX is a specialist primary healthcare REIT which invests in modern, purpose-built primary healthcare properties in the UK & Republic of Ireland. The Company has a portfolio of 151 completed properties with an average value of £4.4m.

MedicX selectively buys high quality dominant assets or forward-funds new schemes under framework agreements with a range of experienced developers in both the UK and the Republic of Ireland.

The fund is listed on the Premium Segment of the Main Market and has a market capitalisation of c.£346m.

Liberum has been appointed as Joint Corporate Broker alongside Canaccord, with immediate effect.

Liberum Team

Board – David Parsons
Investment Banking – Richard Crawley, Jamie Richards, Laura Hamilton, William Hall

Sales – John Mozley
Research – David Brockton
Corporate Access – Lucy Williams

Press Enquiries: Redleaf Polhill

Emailliberum@redleafpr.com

Call: +44 (0)20 7382 4747

Follow Liberum

Twitter@LiberumToday
LinkedInLiberum

 

Liberum appointed Joint Corporate Broker to Crest Nicholson

02 May 2018 |

Crest -1 (1)

Liberum is pleased to announce its appointment as Joint Corporate Broker to Crest Nicholson.

Crest Nicholson is a leading residential developer operating in the Southern half of England with an emphasis on creating well designed homes in sustainable communities. The Group has a wide product range, varying from homes for first time buyers through to large family homes, and includes a mixture of houses, apartments and supporting commercial premises as part of its larger developments.

The Group, which was established over 50 years ago in 1963, has a history of 39 years on the Official List and trading on the London Stock Exchange’s Main Market between 1968 and 2007. The Group re-listed on the London Stock Exchange in 2013.

Crest Nicholson has a market capitalization of £1.2bn and is a constituent of the FTSE 250.

Liberum has been appointed as Joint Corporate Broker alongside Barclays with immediate effect.

Liberum Team

Board - David Parsons

Sales – Julian Collett

Research – Charlie Campbell

Investment Banking – Neil Patel, Richard Bootle, Louis Davies

Corporate Access – Lynsey Cox

Press Enquiries: Redleaf Polhill

Emailliberum@redleafpr.com

Call: +44 (0)20 7382 4747

Follow Liberum

Twitter@LiberumToday
LinkedInLiberum